📊 LFVN Key Takeaways
Is Lifevantage Corp (LFVN) a Good Investment?
Lifevantage demonstrates solid revenue growth of 14.2% YoY and maintains an exceptional gross margin of 77.4%, supported by a fortress balance sheet with zero debt and positive free cash flow. However, severe margin compression (77.4% gross to 3.2% operating) raises material concerns about cost structure and operational efficiency, resulting in anemic 2.7% net margins that limit profitability despite strong top-line performance.
Lifevantage is posting double‑digit revenue growth with a very strong gross margin and a debt‑free balance sheet, indicating improving fundamentals and financial resilience. Yet profitability remains thin and free cash flow is negative, signaling that earnings quality and working‑capital discipline must improve. Sustained margin expansion and conversion of earnings to cash are needed before a more constructive stance.
Lifevantage Corp Key Strengths (LFVN)
- Revenue growth of 14.2% YoY shows market traction
- Exceptional gross margin of 77.4% indicates strong product economics
- Zero long-term debt with debt/equity ratio of 0.00x provides financial flexibility
- Positive free cash flow of $2.9M demonstrates cash generation capability
- Strong liquidity position with 1.96x current ratio and $12.5M cash reserve
- Positive ROE of 11.4% and ROA of 6.1% show capital productivity
- Debt‑free balance sheet with solid liquidity (current ratio 2.03x)
- High gross margin of 76.7% indicating strong unit economics
- Revenue and net income growing YoY (+14.2% revenue, profitability rebound)
LFVN Stock Risks: Lifevantage Corp Investment Risks
- Severe 44.2 percentage point margin compression (gross to operating) indicates unsustainable cost structure or excessive operating expenses
- Net income of only $3.8M on $140.2M revenue (2.7% margin) suggests profitability concerns despite scale
- Operating cash flow of $5.5M leaves limited cushion for growth investments or shareholder returns
- Operating margin of 3.2% is dangerously thin and vulnerable to any revenue decline
- Negative free cash flow and weak operating cash generation
- Thin operating margin (2.9%) leaves little cushion for shocks
- Potential working‑capital volatility creating earnings-to-cash flow disconnect
Key Metrics to Watch
- Operating margin trend - critical to determine if 3.2% can expand toward industry norms
- SG&A and R&D spending as percentage of revenue - understand drivers of the margin compression
- Free cash flow conversion - monitor if FCF margin can improve beyond 2.1%
- Operating cash flow
- Operating margin
Lifevantage Corp (LFVN) Financial Metrics & Key Ratios
💡 AI Analyst Insight
The relatively thin 2.1% FCF margin may limit capital allocation flexibility.
LFVN Profit Margin, ROE & Profitability Analysis
LFVN vs Healthcare Sector: How Lifevantage Corp Compares
How Lifevantage Corp compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Lifevantage Corp Stock Overvalued? LFVN Valuation Analysis 2026
Based on fundamental analysis, Lifevantage Corp has mixed fundamental signals relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Lifevantage Corp Balance Sheet: LFVN Debt, Cash & Liquidity
LFVN Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Lifevantage Corp's revenue has remained relatively flat over the 5-year period, with a 2% decline. The most recent EPS of $0.23 reflects profitable operations.
LFVN Revenue Growth, EPS Growth & YoY Performance
LFVN Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2026 | $43.7M | $276.0K | $0.11 |
| Q2 2026 | $48.9M | $276.0K | $0.02 |
| Q1 2026 | $47.2M | $1.8M | $0.14 |
| Q3 2025 | $48.2M | $629.0K | $0.13 |
| Q2 2025 | $51.6M | -$27.0K | $0.00 |
| Q1 2025 | $47.2M | $629.0K | $0.05 |
| Q3 2024 | $48.2M | $574.0K | $0.05 |
| Q2 2024 | $51.6M | -$27.0K | $0.00 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Lifevantage Corp Dividends, Buybacks & Capital Allocation
LFVN SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Lifevantage Corp (CIK: 0000849146)
📋 Recent SEC Filings
❓ Frequently Asked Questions about LFVN
What is the AI rating for LFVN?
Lifevantage Corp (LFVN) has a Combined AI Grade of B from Claude (B) and ChatGPT (B) with 64% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are LFVN's key strengths?
Claude: Revenue growth of 14.2% YoY shows market traction. Exceptional gross margin of 77.4% indicates strong product economics. ChatGPT: Debt‑free balance sheet with solid liquidity (current ratio 2.03x). High gross margin of 76.7% indicating strong unit economics.
What are the risks of investing in LFVN?
Claude: Severe 44.2 percentage point margin compression (gross to operating) indicates unsustainable cost structure or excessive operating expenses. Net income of only $3.8M on $140.2M revenue (2.7% margin) suggests profitability concerns despite scale. ChatGPT: Negative free cash flow and weak operating cash generation. Thin operating margin (2.9%) leaves little cushion for shocks.
What is LFVN's revenue and growth?
Lifevantage Corp reported revenue of $140.2M.
Does LFVN pay dividends?
Lifevantage Corp pays dividends, with $1.7M distributed to shareholders in the trailing twelve months.
Where can I find LFVN SEC filings?
Official SEC filings for Lifevantage Corp (CIK: 0000849146) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is LFVN's EPS?
Lifevantage Corp has a diluted EPS of $0.30.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined grade reflects both perspectives for balanced insights.
What is LFVN's fundamental grade?
Based on our AI fundamental analysis in May 2026, Lifevantage Corp has a B grade with 64% confidence. Review the strengths and risks sections above for full context. This is not investment advice.
Is LFVN stock overvalued or undervalued?
Valuation metrics for LFVN: ROE of 11.4% (sector avg: 15%), net margin of 2.7% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
What is LFVN's AI grade for 2026?
Our dual AI analysis gives Lifevantage Corp a combined B grade for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is LFVN's free cash flow?
Lifevantage Corp's operating cash flow is $5.5M, with capital expenditures of $2.5M. FCF margin is 2.1%.
How does LFVN compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin 2.7% (avg: 12%), ROE 11.4% (avg: 15%), current ratio 1.96 (avg: 2).